Literature DB >> 4246871

Malignant hyperthermia: a statistical review.

B A Britt, W Kalow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4246871     DOI： 10.1007/bf03004694

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


× No keyword cloud information.
  34 in total

1.  THE MODERN TREATMENT OF SHOCK BASED ON PHYSIOLOGIC PRINCIPLES.

Authors:  R C LILLEHEI; J K LONGERBEAM; J H BLOCH; W G MANAX
Journal:  Clin Pharmacol Ther       Date:  1964 Jan-Feb       Impact factor: 6.875

2.  Mechanism of digitalis action on the heart.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1967-08-31       Impact factor: 91.245

3.  Hyperpyrexia during anaesthesia.

Authors:  S Hogg; W Renwick
Journal:  Can Anaesth Soc J       Date:  1966-09

4.  Hereditary aspects of malignant hyperthermia.

Authors:  B A Britt; W G Locher; W Kalow
Journal:  Can Anaesth Soc J       Date:  1969-03

5.  Hyperthermia during anesthesia.

Authors:  D Crocker; H Blum; J G Adams; R M Smith
Journal:  Anesth Analg       Date:  1969 Sep-Oct       Impact factor: 5.108

6.  A simple method for the early detection of the malignant hyperpyrexia of anaesthesia and hypothesis.

Authors:  H McGavock
Journal:  Ir J Med Sci       Date:  1969-06       Impact factor: 1.568

7.  Clinical anesthesia conference: fulminating hyperthermia during anesthesia.

Authors: 
Journal:  N Y State J Med       Date:  1968-10-01

8.  Anesthesia and malignant hyperpyrexia.

Authors:  M J Soderberg
Journal:  J Am Assoc Nurse Anesth       Date:  1969-10

9.  [Hyperpyrexia during general anaesthesia: a case report].

Authors:  G Lavoie
Journal:  Can Anaesth Soc J       Date:  1966-09

10.  Malignant hyperpyrexia with anesthesia.

Authors:  R D Wilson; T E Dent; D L Traber; N R McCoy; C R Allen
Journal:  JAMA       Date:  1967-10-16       Impact factor: 56.272
View more
  79 in total

1.  Hyperthermia associated with ophthalmic surgery.

Authors:  H Beasley
Journal:  Trans Am Ophthalmol Soc       Date:  1973

2.  Aborted malignant hyperthermia: case report.

Authors:  A S Carballo
Journal:  Can Anaesth Soc J       Date:  1975-03

3.  Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.

Authors:  F R Ellis; I M Clarke; M Modgill; S Currie; D G Harriman
Journal:  Br Med J       Date:  1975-08-30

Review 4.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

5.  Letter: Malignant hyperpyrexia.

Authors:  J N Lucke; D Lister; G M Hall
Journal:  Br Med J       Date:  1975-02-22

6.  Anesthesia for surgery of strabismus.

Authors:  R B Smith
Journal:  Bull N Y Acad Med       Date:  1975-03

7.  Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.

Authors:  S J Healy; J J Heffron; M Lehane; D G Bradley; K Johnson; T V McCarthy
Journal:  BMJ       Date:  1991-11-16

Review 8.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

9.  Biochemical basis of malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1974-05-04

10.  Ten cases of malignant hyperthermia in Norway.

Authors:  J Stovner; K R Innes; A Holen
Journal:  Can Anaesth Soc J       Date:  1976-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.